Cipla gets India approval to sell COVID-19 drug favipiravir
BENGALURU (Reuters) – Cipla Ltd has received Indian regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drugmaker…
Glenmark cuts price of COVID-19 drug favipiravir version to $1 per tablet
BENGALURU (Reuters) – Glenmark Pharmaceuticals Ltd said on Monday it would lower the price of its generic version of favipiravir,…